General Announcement::J. P. Morgan Healthcare Conference, San Francisco, USA Presentation

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
10-Jan-2018 16:19:58
Status
New
Announcement Sub Title
J. P. Morgan Healthcare Conference, San Francisco, USA Presentation
Announcement Reference
SG180110OTHRA93T
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
10/01/2018 13:00:00
Description (Please provide a detailed description of the event in the box below)
Sub: J. P. Morgan Healthcare Conference, San Francisco, USA Presentation

With reference to the subject mentioned above, kindly find attached media release which is self-explanatory.

Request you to kindly take the same on record.

Attachments

SGX_Press Release.pdf
Total size =978K